Dashenlin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 33.8% in First Half of 2023

Dashenlin Pharmaceutical Group Co.,Ltd. (大参林医药集团股份有限公司) (603233.SH) reported a net profit of 1 billion yuan in the first half of 2023, up 33.8% year-on-year.

Meanwhile, the company posted 12 billion yuan in revenue, up 23.4% year-on-year.

At the end of the reporting period, it had 20.8 billion yuan in total assets and 13.2 billion yuan in total liabilities, with a liability-to-asset ratio of 63.3%.